Loading...
XKRX004540
Market cap59mUSD
Jan 10, Last price  
2,360.00KRW
1D
-1.05%
1Q
7.76%
Jan 2017
-58.74%
Name

Kleannara Co Ltd

Chart & Performance

D1W1MN
XKRX:004540 chart
P/E
—
P/S
0.17
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
-0.01%
Rev. gr., 5y
-3.84%
Revenues
514.85b
-15.10%
402,177,083,000466,820,868,000498,127,015,000526,163,789,000587,818,671,070633,378,794,220647,438,802,680656,459,355,000678,615,391,170706,033,014,920659,937,159,160626,328,188,470594,158,566,680591,566,240,710578,743,925,040606,453,743,470514,854,128,370
Net income
-30.84b
L+960.52%
-19,698,763,000-29,428,217,000-2,959,600,0003,785,406,0001,186,614,00014,372,455,25016,070,006,6202,634,567,650-1,500,995,7807,465,089,480-22,495,341,000-33,794,185,000-11,786,429,61038,098,726,0208,362,663,520-2,908,390,760-30,844,136,630
CFO
34.24b
P
4,627,475,0006,227,834,00025,987,898,00031,738,123,00033,874,614,00040,817,845,91024,480,681,43017,687,188,10016,344,308,68050,061,040,600-2,879,384,670-22,458,641,13025,519,295,23062,154,272,79031,366,478,810-5,359,463,94034,241,434,890
Dividend
Dec 29, 2020100 KRW/sh

Profile

KleanNara Co., Ltd. manufactures and sells paper products in South Korea. The company offers rolls, cosmetic tissues, kitchen towels, wet wipes, sanitary pads, diapers for babies and adults, jumbo rolls, hand towels, and napkins. It also provides hand sanitizer gels; industrial packaging papers for pharmaceuticals, cosmetics, household items, confectionery, and stationery; food packing papers; and special papers for transportation of refrigerated/frozen goods and heavy containers. The company also exports its products to approximately 40 countries under the White Horse and Best Coat brands. KleanNara Co., Ltd. was founded in 1966 and is headquartered in Seoul, South Korea.
URL
https://www.kleannara.co.kr/Main/main
IPO date
Jun 25, 1975
Employees
Domiciled in
KR
Incorporated in
KR

Valuation

Title
KRW in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
514,854,128
-15.10%
606,453,743
4.79%
Cost of revenue
514,218,688
579,713,720
Unusual Expense (Income)
NOPBT
635,440
26,740,024
NOPBT Margin
0.12%
4.41%
Operating Taxes
(493,436)
232,762
Tax Rate
0.87%
NOPAT
1,128,876
26,507,262
Net income
(30,844,137)
960.52%
(2,908,391)
-134.78%
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
192,800,256
138,761,094
Long-term debt
144,916,078
187,602,981
Deferred revenue
8,048,433
9,734,559
Other long-term liabilities
1,925,821
3,101,978
Net debt
283,338,518
304,640,877
Cash flow
Cash from operating activities
34,241,435
(5,359,464)
CAPEX
(15,863,027)
(33,583,606)
Cash from investing activities
(15,236,479)
(59,837,683)
Cash from financing activities
5,832,435
62,734,693
FCF
35,891,795
(12,711,502)
Balance
Cash
41,753,872
33,751,662
Long term investments
12,623,944
(12,028,464)
Excess cash
28,635,110
Stockholders' equity
115,124,971
239,949,730
Invested Capital
513,236,126
563,858,104
ROIC
0.21%
4.99%
ROCE
0.11%
4.63%
EV
Common stock shares outstanding
37,239
37,239
Price
2,425.00
-13.39%
2,800.00
-31.62%
Market cap
90,305,174
-13.39%
104,269,892
-31.62%
EV
374,009,852
409,276,928
EBITDA
36,115,986
61,069,159
EV/EBITDA
10.36
6.70
Interest
14,134,417
8,945,945
Interest/NOPBT
2,224.35%
33.46%